TokenPost·

BeOne Raises 2026 Revenue Outlook to $6.9 Billion to $7 Billion

Your call?

Third-quarter sales rose 34% to $1.4 billion, and U.S. BRUKINSA sales topped $1 billion. The tacabrutideg filing plan follows an FDA request for additional follow-up.

Share

More news